[protected-iframe id=”de0eca492e7b7cb1dc5c199c0a63cd17-7618883-121704370″ info=”https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/560495631&color=%23ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&show_teaser=true” width=”100%” height=”166″ scrolling=”no”] [khn_slabs slabs=”821957″] [khn_slabs slabs=”821984″] [khn_slabs slabs=”821954″] [khn_slabs slabs=”821951″] Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is […]Continue Reading ...
A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development. Their findings appear in the journal Nature Chemistry. Many pharmaceuticals contain aliphatic and aromatic carbon-hydrogen […]Continue Reading ...
Researchers at the University of California, Berkeley, have developed a polymer sponge that absorbs excess chemotherapy drugs from the bloodstream following treatment. stockfour | Shutterstock The “drug sponge” could help prevent the dangerous side effects of toxic chemotherapy agents or even enable the delivery of higher doses to treatment-resistant tumors such as liver cancer. The […]Continue Reading ...
Jan 11 2019 Published in the Peer-Reviewed Journal mAbs, the Paper Introduces Complex-Specific Antibodies for Pharmacokinetic Analysis of Biotherapeutics Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, has published new findings on the generation and characterization of drug-target complex-specific antibodies for pharmacokinetic (PK) analysis of biotherapeutics. The paper published […]Continue Reading ...
Until now, it’s been difficult for clinicians to determine which patients are most likely to relapse after treatment for drug addiction. But that could change, if preliminary results from new Stanford research hold up. In a study of 36 people receiving treatment for stimulant use disorders (like cocaine and amphetamines), psychologists were able to correctly […]Continue Reading ...
Treatment for Prevention of Cisplatin-Induced Ototoxicity Fennec Pharmaceuticals Initiates Rolling New Drug Application to FDA for Pedmark Research Triangle Park, NC, December 20, 2018 – Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, following a pre-submission meeting with the oncology division of the U.S. Food and Drug Administration (FDA), has initiated a rolling […]Continue Reading ...
Ted Allison (left) and Michele DuVal found that telbivudine, a drug already approved to treat hepatitis, may slow the progression of ALS. Credit: John Ulan A drug typically used to treat hepatitis could slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta scientists. The drug, […]Continue Reading ...
Aptamer Group today announced it has signed an agreement with AstraZeneca to explore the potential of using aptamer technology to target the kidney. The two-year agreement will give AstraZeneca use of Aptamer Group’s proprietary technology to explore the feasibility of developing the next generation of drug delivery vehicles, called Aptamer Drug Conjugates (ApDCs). Aptamers are […]Continue Reading ...
A Michigan State University researcher has received a $2.8 million federal grant to develop a gene therapy that could reduce and possibly eliminate a frustrating side effect of a drug commonly prescribed to Parkinson’s patients. The research could mean a significant advance for the up to 90 percent of patients who develop dyskinesia, a drug-induced […]Continue Reading ...
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma. Dabrafenib plus trametinib is approved for the adjuvant treatment of adult patients with stage III […]Continue Reading ...
Researchers from LSTM and the University of Liverpool have successfully optimized a hit from a whole cell screening of a 10000-compound library to deliver the first novel fully synthetic and rationally designed anti-Wolbachia drug, AWZ1066S, which could potentially be used to treat onchocerciasis and lymphatic filariasis (LF). LSTM’s Deputy Director, Professor Steve Ward, is co-senior […]Continue Reading ...
In an editorial published in CNS Spectrums, Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS). Noting that the disease course of MS in African American (AA) patients is more aggressive, he urged researchers to make […]Continue Reading ...
lefamulin Treatment for Pneumonia Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults DUBLIN, Ireland, Dec. 20, 2018 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of innovative anti-infective agents […]Continue Reading ...
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at The Longevity Therapeutics 2019 in San Francisco, 30 of January. Artificial Intelligence (AI) techniques, such as deep learning (DL), reinforcement learning (RL), and generative […]Continue Reading ...
- Breast cancers more likely to metastasize in young women within 10 years of giving birth
- Blood vessels can now be created perfectly in a petri dish
- Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk
- For-profit nursing schools associated with lower performance on nurse licensure test
- Considering the culture of consent in medicine
- Researchers identify comprehensive guidelines for managing severe atopic dermatitis
- Analyzing proteins in blister fluid may classify burn severity more accurately
- Study finds higher suicide rates among youth who were Medicaid enrollees
- Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons
- New biodegradable wound dressing material accelerates healing
- Life in Space May Take Toll on Spinal Muscles
- Bulldogs’ screw tails linked to human genetic disease
- Immunotherapy target identified for pediatric cancers
- Financial stress may increase heart disease risk in African Americans
- Scientists solve another piece of Ebola virus puzzle
- New project finds how endocrine disruptors interfere with thyroid functions
- Research finds decline in ketone body utilization when coronary circulation is reduced
- Let’s map our DNA and save billions each year in health costs
- AI demonstrates potential to identify irregular heart rhythms as well as humans
- Study shows link between air pollution and increased risk of sleep apnea